Alembic Pharma share price continues to rally for the second consecutive day. It is up over 5 percent, hitting fresh 52-week high after the company reported healthy growth in earnings for the March quarter. The drug maker has reported an 81.4 percent year-on-year (YoY) growth in Q4 profit at Rs 225 crore on a revenue of Rs 12.07 billion that grew by 30.2 percent.
For the year, Alembic Pharma's profit surged 41.88 percent to Rs 8.29 billion and revenue from operations increased 17.06 percent to Rs 46.05 billion.